newsfilter
← Latest News
GlobeNewswire·

AEON Biopharma, Inc. Announces Reverse Stock Split

IRVINE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE:AEON) (the "Company"), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar